melphalan [clinicaltrials_resource:eea46b0ae003619cc4cf0332b03a5e35]
A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma [clinicaltrials:NCT00001296]Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma [clinicaltrials:NCT00002599]High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse [clinicaltrials:NCT00002630]Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma [clinicaltrials:NCT00002653]Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer [clinicaltrials:NCT00002680]Chemotherapy in Treating Children With Neuroblastoma [clinicaltrials:NCT00002730]Melphalan in Patients With Neoplastic Meningitis [clinicaltrials:NCT00002750]Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma [clinicaltrials:NCT00002802]High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis [clinicaltrials:NCT00002810]Melphalan and Whole-Body Hyperthermia in Treating Patients With Advanced Melanoma [clinicaltrials:NCT00002973]Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission [clinicaltrials:NCT00002977]Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma [clinicaltrials:NCT00002982]Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002989]Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma [clinicaltrials:NCT00003007]Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer [clinicaltrials:NCT00003080]Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma [clinicaltrials:NCT00003081]Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer [clinicaltrials:NCT00003086]Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003146]Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers [clinicaltrials:NCT00003163]Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003215]High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis [clinicaltrials:NCT00003353]Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003396]Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003397]Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003399]Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer [clinicaltrials:NCT00003400]Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003401]Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [clinicaltrials:NCT00003402]Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer [clinicaltrials:NCT00003413]Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer [clinicaltrials:NCT00003435]Rituximab in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003554]High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003578]Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003603]Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma [clinicaltrials:NCT00003631]Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Central Nervous System Lymphoma [clinicaltrials:NCT00003632]Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003661]Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases [clinicaltrials:NCT00003662]Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00003727]Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003815]Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors [clinicaltrials:NCT00003899]Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003957]
intervention [clinicaltrials_vocabulary:intervention]
melphalan [clinicaltrials_resource:eea46b0ae003619cc4cf0332b03a5e35]
Bio2RDF identifier
eea46b0ae003619cc4cf0332b03a5e35
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:eea46b0ae003619cc4cf0332b03a5e35
intervention name [clinicaltrials_vocabulary:intervention-name]
identifier
clinicaltrials_resource:eea46b0ae003619cc4cf0332b03a5e35
title
melphalan
@en
type
label
melphalan [clinicaltrials_resource:eea46b0ae003619cc4cf0332b03a5e35]
@en